|
⚲
|
| Keyboard |
| Robert Hershberg | |
|---|---|
| Firm | |
| Address | 99 Wall Street, 2205 New York, NY 10005 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Eleusis Holdings Ltd | 021-435893 | Director | 0.5 M of 50.0 M |
||
| Silverback Therapeutics Inc | 021-377225 | Director | 85.0 M of 85.0 M |
||
| Recursion Pharmaceuticals Inc | 021-375551 | Director | 245.9 M of 245.9 M |
||
| Guide Therapeutics Inc | 021-373893 | Director | 5.9 M of 5.9 M |
||
| Fate Therapeutics Inc | 021-370287 | Director | 50.0 M of 50.0 M |
||
| Silverback Therapeutics Inc | 021-363266 | Director | 31.8 M of 78.7 M |
||
| Silverback Therapeutics Inc | 021-321856 | Director | 12.5 M of 20.0 M |
||
| Silverback Therapeutics Inc | 021-302681 | Director | 0.0 M of 0.0 M |
||